Dysautonomia in Autism: Symptoms, Causes, Testing and Treatment
Dysautonomia means that the autonomic nervous system is not regulating automatic body functions normally. In children and adolescents this may appear as dizziness, rapid heart rate, fainting, heat intolerance, abnormal sweating, gastrointestinal symptoms, fatigue, headaches, sleep disturbance or exercise intolerance. Autonomic abnormalities have been reported in some autistic children, but dysautonomia is not present in every child with autism and should not be assumed from behavior alone.
What Does Dysautonomia Mean?
The autonomic nervous system controls functions that normally occur without conscious effort. These include heart rate, blood pressure, circulation, sweating, temperature regulation, digestion, bladder function, pupil responses and aspects of breathing.
Dysautonomia is an umbrella term rather than one single diagnosis. It can occur as a primary nervous-system disorder or as a secondary effect of another condition. In children and adolescents, orthostatic intolerance and postural orthostatic tachycardia syndrome are among the most commonly discussed forms.
Cardiovascular control
Heart rate, blood pressure, blood-vessel constriction and blood return to the heart.
Temperature and sweating
Heat tolerance, sweating, skin blood flow and the ability to cool the body.
Digestion and bladder function
Motility, nausea, constipation, diarrhea, urinary urgency or retention.
Stress and sensory response
Sympathetic arousal, vagal recovery, sleep, startle and physiological flexibility.
What Symptoms Can Dysautonomia Cause in Children?
Standing and circulation
- Dizziness or lightheadedness
- Rapid heartbeat on standing
- Fainting or near-fainting
- Leg discoloration or blood pooling
- Weakness after standing or showering
Energy and neurological symptoms
- Fatigue and exercise intolerance
- Headaches or “brain fog”
- Visual dimming
- Tremulousness
- Sleep disruption
Temperature, gut and sensory symptoms
- Heat intolerance
- Excessive or reduced sweating
- Nausea, abdominal pain or constipation
- Food intolerance or early fullness
- Heightened sensory or stress reactions
Why Is Dysautonomia Sometimes Diagnosed in Autistic Children?
Research suggests that a subset of autistic people has altered autonomic regulation, including differences in heart-rate variability, sympathetic arousal, parasympathetic recovery and vascular responses. Other studies have found substantial variability, so autonomic dysfunction should not be treated as a universal feature of autism.
Dysautonomia may be more noticeable in autism because sensory overload, anxiety, sleep disruption, gastrointestinal symptoms, limited fluid intake, selective eating, deconditioning, hypermobility and difficulty reporting internal symptoms can all complicate recognition and management.
Autonomic hyperarousal
Persistent sympathetic activation may contribute to distress, sleep problems and difficulty recovering after sensory or social stress.
Hypermobility overlap
Joint hypermobility and connective-tissue disorders are associated with orthostatic intolerance in some neurodivergent patients.
Communication barriers
A child may communicate physiological distress through behavior rather than through a clear description of dizziness or tachycardia.
POTS and Other Forms of Orthostatic Intolerance
| Pattern | Typical feature | Important distinction |
|---|---|---|
| POTS | Excessive sustained heart-rate rise after standing with orthostatic symptoms | In adolescents, commonly uses an increase of at least 40 beats per minute within 10 minutes, without orthostatic hypotension and after excluding other causes. |
| Orthostatic hypotension | Blood pressure falls significantly after standing | Not the same as POTS, although symptoms can overlap. |
| Vasovagal syncope | Reflex drop in blood pressure and/or heart rate leading to fainting | Often triggered by prolonged standing, pain, emotional stress or medical procedures. |
| Inappropriate sinus tachycardia | Persistently high sinus heart rate, including outside standing | Requires exclusion of fever, anemia, thyroid disease, dehydration, medication effects and other causes. |
| Autonomic neuropathy | Damage to small autonomic nerve fibers | May affect sweating, circulation, digestion and bladder function. |
What Causes Dysautonomia?
Dysautonomia usually develops from interacting vulnerabilities rather than one universal cause. The following categories are clinically useful:
Genetic and connective-tissue factors
- Familial autonomic disorders
- Hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder
- Ion-channel or metabolic disorders in selected cases
- Inherited mitochondrial disease in a small subgroup
Post-infectious and immune factors
- Viral illness
- Long COVID or other post-acute infection syndromes
- Autoimmune autonomic neuropathy
- Mast-cell or inflammatory overlap in selected patients
Blood volume and conditioning
- Low fluid or salt intake
- Deconditioning after illness
- Prolonged bed rest
- Low body weight or inadequate calories
- Blood loss or anemia
Medication and substance effects
- Stimulants or activating medications
- Blood-pressure-lowering drugs
- Diuretics
- Sedating medications that reduce activity
- Cannabis, nicotine or other substances
Nutrition and metabolic disease
- Iron, B12, folate or vitamin D deficiency
- Low protein or restrictive diet
- Thyroid disease
- Hypoglycemia or insulin dysregulation
- Electrolyte imbalance
Mitochondrial and oxidative burden
- Reduced ATP production
- Oxidative stress
- Low glutathione or antioxidant reserve
- Toxic exposure according to history
- Chronic inflammation or poor sleep
Can Dysautonomia Follow Vaccination?
Case reports and observational studies have described POTS or other autonomic symptoms after vaccination, including after COVID-19 vaccines. A temporal association does not by itself prove causation, and available data indicate that POTS is more commonly reported after SARS-CoV-2 infection than after COVID-19 vaccination.
Vaccines should not be presented as a common cause of autism or dysautonomia
Large epidemiologic studies have not established routine childhood vaccination as a cause of autism. For an individual child whose symptoms began after a vaccine, the timing should be documented and evaluated without dismissing the history—but the workup should still examine infection, dehydration, anemia, thyroid disease, hypermobility, medications, nutrition, mitochondrial stress and other established causes.
The practical approach is to distinguish a true new autonomic syndrome from a brief fever, reduced intake, vasovagal reaction or temporary post-immunization symptoms. Persistent orthostatic symptoms deserve objective standing heart-rate and blood-pressure measurements and a conventional medical evaluation.
Mitochondria, ATP and Autonomic Regulation
The autonomic nervous system depends on continuous ATP production. Neurons must maintain ion gradients, release neurotransmitters, regulate vascular tone and adapt quickly to changes in posture, temperature, digestion and stress. When mitochondrial energy is limited, exercise, standing, heat and sensory stress may become harder to tolerate.
How Mitochondrial Stress May Worsen Autonomic Symptoms
This does not mean that mitochondrial supplements alone will correct POTS. Low blood volume, venous pooling, hypermobility, autonomic neuropathy, medication effects and immune triggers may require different treatment.
Read: Mitochondria, SOD Enzymes, Oxidative Stress and MethylationUndermethylation, Copper and Toxic Burden: Possible Functional Contributors
The Walsh biotypes are not established diagnostic categories for dysautonomia. They may nevertheless help organize laboratory findings and treatment reactions in a child who also has anxiety, obsessive traits, sleep problems, copper-zinc imbalance, pyroluria or oxidative stress.
Undermethylation
High whole-blood histamine, low SAM, elevated SAH or strong folate sensitivity may coexist with autonomic symptoms. This does not prove causation. ATP, protein, zinc, vitamin B6, creatine demand and mitochondrial function may all influence methylation capacity.
Copper and prenatal influences
Copper rises during pregnancy and is essential for fetal development. Maternal copper, zinc, inflammation and nutrition may influence fetal biology, but there is no validated test showing that prenatal copper exposure causes later dysautonomia. In the child, copper, ceruloplasmin and zinc can be measured when symptoms or history justify evaluation.
Toxic burden
Toxic burden includes more than heavy metals. It may include oxidative stress, poor sleep, inflammation, constipation, dehydration, medication load, metabolic disease, environmental exposure and inadequate liver or kidney clearance.
Which Tests Are Used for Dysautonomia?
Testing begins with objective cardiovascular measurements and exclusion of common medical causes. Functional laboratory testing is secondary and should answer a specific clinical question.
| Test | What it evaluates | Clinical use |
|---|---|---|
| Orthostatic vital signs | Heart rate and blood pressure while supine and during up to 10 minutes of standing | First-line screen for POTS, orthostatic hypotension and orthostatic intolerance |
| ECG | Heart rhythm and conduction | Helps exclude arrhythmia or conduction abnormalities |
| Tilt-table test | Controlled heart-rate and blood-pressure response to upright tilt | Used when standing measurements are unclear or syncope requires further evaluation |
| Autonomic reflex testing | Heart-rate variability, breathing response, adrenergic function and sweating | Useful in suspected autonomic neuropathy or complex dysautonomia |
| CBC, ferritin and metabolic panel | Anemia, iron status, electrolytes, kidney and liver function | Excludes common causes of tachycardia, weakness and dizziness |
| Thyroid and glucose testing | Endocrine and metabolic contributors | Helps distinguish dysautonomia from hyperthyroidism or glucose instability |
| Nutrition and biochemical testing | B12, folate, vitamin D, copper, ceruloplasmin, zinc, manganese, homocysteine, SAM and SAH | Used selectively when diet, methylation, oxidative stress or copper-zinc imbalance is clinically relevant |
| Cellular stress testing | 8-OHdG, glutathione, glutathione peroxidase, SOD activity or related markers | May document oxidative burden but does not diagnose POTS by itself |
How Is Pediatric Dysautonomia Treated?
Treatment should be matched to the autonomic pattern and the child’s underlying causes. The strongest starting point is usually a structured non-drug program rather than a large supplement list.
Fluids and salt
- Consistent daily fluid intake
- Additional sodium when approved by the treating clinician
- Electrolyte solutions rather than excessive plain water in selected patients
- Monitoring for hypertension, kidney disease or other contraindications
Physical reconditioning
- Begin with recumbent or semi-recumbent exercise
- Gradually build leg and core muscle
- Avoid prolonged bed rest when medically possible
- Use rehabilitation support when the child is severely deconditioned
Daily symptom management
- Compression garments when tolerated
- Slow position changes
- Cooler showers and heat avoidance
- Regular meals with adequate protein and calories
- School accommodations and rest periods
Medications used in selected patients
Depending on the subtype and cardiovascular findings, clinicians may use fludrocortisone, midodrine, beta blockers, ivabradine, pyridostigmine or other medications. These are not interchangeable. Blood pressure, resting heart rate, symptom pattern, age, hydration and coexisting conditions determine which approach is appropriate.
Supplements that may be considered
Electrolytes
Sodium and electrolyte support can help low-volume or orthostatic patterns, but dosing should be individualized and coordinated with the child’s physician.
Iron, B12, folate and vitamin D
Correct documented deficiencies. Folate should not be prescribed automatically when the child has a history of activation, undermethylation or unusual reactions.
Magnesium
May support muscle and nervous-system function, but excessive dosing can worsen diarrhea or lower blood pressure.
CoQ10 and creatine
May support cellular energy in selected patients. Creatine can also reduce methylation demand, but neither replaces fluid, salt, rehabilitation or treatment of the actual autonomic subtype.
NAC, glycine or glutathione support
May be considered when oxidative stress or low antioxidant reserve is documented. Tolerance varies, particularly in chemically sensitive children.
Zinc, manganese and selenium
These minerals support antioxidant enzymes, but both deficiency and excess are harmful. Test before using high doses.
Do not treat “dysautonomia” with one universal supplement protocol
A child with low blood volume, another with hyperadrenergic POTS, and another with autonomic neuropathy may need different treatment. Supplements can also interact with psychiatric, cardiovascular and neurological medications.
When Is Urgent Evaluation Needed?
- Chest pain, severe shortness of breath or sustained abnormal heart rhythm
- Fainting during exercise
- New weakness, paralysis, seizures or major neurological change
- Persistent vomiting, severe dehydration or inability to maintain intake
- Unexplained weight loss
- Family history of sudden cardiac death
- Rapid developmental regression or loss of previously acquired function
- Symptoms suggesting adrenal crisis, severe anemia, infection or metabolic disease
Selected Scientific Sources
- Owens AP, et al. Autonomic Dysfunction in Autism Spectrum Disorder. Frontiers in Integrative Neuroscience. 2021.
- Benevides TW, Lane SJ. A review of cardiac autonomic measures in autism spectrum disorder. Autism Research. 2015.
- Raj SR, et al. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022.
- Boris JR. Pediatric postural orthostatic tachycardia syndrome. Autonomic Neuroscience. 2022.
- Huynh P, et al. Management of postural orthostatic tachycardia syndrome in pediatric patients. Journal of Pediatric Pharmacology and Therapeutics. 2024.
- Yong SJ, et al. POTS following SARS-CoV-2 infection and vaccination. 2023.